Generate Biomedicines Inc (GENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 177,696 |
| Marketable Securities | 217,358 |
| Receivables | 308 |
| Other current assets | 12,129 |
| TOTAL | $407,491 |
| Non-Current Assets | |
| PPE Net | 72,864 |
| Other Non-Current Assets | 9,700 |
| TOTAL | $82,564 |
| Total Assets | $518,259 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 5,667 |
| Accrued Expenses | 21,771 |
| Other current liabilities | 42,471 |
| TOTAL | $86,626 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 790,723 |
| TOTAL | $812,344 |
| Total Liabilities | $952,778 |
| Shareholders' Equity | |
| Common Shares | 33 |
| Retained earnings | -473,139 |
| Other shareholders' equity | 118 |
| TOTAL | $-434,519 |
| Total Liabilities And Equity | $518,259 |